BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 73409)

  • 1. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
    Mosende C; Gutierrez M; Caparros B; Rosen G
    Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy of malignant bone tumors].
    Wilmanns W; Sauer H; Schalhorn A
    Langenbecks Arch Chir; 1982; 358():393-8. PubMed ID: 6963363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
    Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
    J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy in osteogenic sarcoma: the Memorial Sloan-Kettering cancer center experience (author's transl)].
    Jürgens H; Rosen G
    Klin Padiatr; 1980 Mar; 192(2):123-9. PubMed ID: 6158596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
    Tefft M; Chabora BM; Rosen G
    Cancer; 1977 Feb; 39(2 Suppl):806-16. PubMed ID: 402197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of adjuvant chemotherapy in osteogenic sarcoma.
    Sutow WW; Sullivan MP; Wilbur JR; Cangir A
    J Clin Pharmacol; 1975 Jul; 15(7):530-3. PubMed ID: 1097476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
    Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
    Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
    Jürgens H; Beron G; Winkler K
    J Cancer Res Clin Oncol; 1983; 106 Suppl():14-8. PubMed ID: 6350313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
    Pratt CB; Epelman S; Jaffe N
    Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.